» Articles » PMID: 38686259

Management of COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS) During Pregnancy Following In Vitro Fertilization (IVF)

Overview
Journal Cureus
Date 2024 Apr 30
PMID 38686259
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is recognized for its heterogeneous clinical presentation, complex pathophysiology, and broad spectrum of manifestations. Obstetric patients have been a subject of considerable interest due to their potential vulnerability to more severe infection and adverse pregnancy outcomes, exemplified by this report of a 43-year-old pregnant female with severe COVID-19 infection and respiratory complications. This case report aims to contribute to the existing scientific knowledge by presenting a detailed clinical profile of a patient with COVID-19 who achieved pregnancy through in vitro fertilization (IVF) and discussing the management and outcomes of the infection. The neonate's negative COVID-19 tests suggest no intrauterine transmission; prompt medical interventions, including mechanical ventilation and targeted antibiotic therapy, were implemented to stabilize her condition. Close collaboration among the multidisciplinary team and careful monitoring of vital functions and laboratory parameters were crucial in managing the patient's complex condition. Thus, this case highlights the importance of a comprehensive and multidisciplinary approach in managing severe COVID-19 cases in pregnancy, emphasizing the need for prompt recognition of complications and timely intervention.

References
1.
Szecsi P, Jorgensen M, Klajnbard A, Andersen M, Colov N, Stender S . Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010; 103(4):718-27. DOI: 10.1160/TH09-10-0704. View

2.
Lombardi A, Duiella S, Li Piani L, Comelli A, Ceriotti F, Oggioni M . Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study. Sci Rep. 2021; 11(1):13350. PMC: 8233302. DOI: 10.1038/s41598-021-92885-7. View

3.
Duca L, Nava I, Vallisa D, Vadacca G, Magnacavallo A, Vercelli A . COVID-19, inflammatory response, iron homeostasis and toxicity: a prospective cohort study in the Emergency Department of Piacenza (Italy). Acta Biomed. 2022; 93(2):e2022057. PMC: 9171873. DOI: 10.23750/abm.v93i2.12937. View

4.
Ali N . Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020; 92(11):2409-2411. PMC: 7301027. DOI: 10.1002/jmv.26097. View

5.
Sproston N, Ashworth J . Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018; 9:754. PMC: 5908901. DOI: 10.3389/fimmu.2018.00754. View